...
首页> 外文期刊>Frontiers in Cardiovascular Medicine >Clinical Impact of Thrombus Aspiration and Interaction With D-Dimer Levels in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
【24h】

Clinical Impact of Thrombus Aspiration and Interaction With D-Dimer Levels in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

机译:血栓吸入与患者D-二聚体水平的临床影响,患有初级经皮冠状动脉介入的心肌梗死患者

获取原文
           

摘要

Objectives: To evaluate the effect of thrombus aspiration (TA) strategy on the outcomes and its interaction with D-dimer levels in patients with ST-segment elevation myocardial infarction (STEMI) during primary percutaneous coronary intervention (PCI) in “real-world” settings. Materials and Methods: This study included 1,295 patients with STEMI who had undergone primary PCI with or without TA between January 2013 and June 2017. Patients were first divided into a TA+PCI group and a PCI-only group, and the baseline characteristics and long-term mortality between the two groups were analyzed. Furthermore, we studied the effect of TA on the clinical outcomes of patients grouped according to quartiles of respective D-dimer levels. The primary outcome was all-cause mortality, and the secondary outcomes were new-onset heart failure (HF), rehospitalization, re-PCI, and stroke. Results: In the original cohort, there were no significant differences in all-cause mortality between the TA+PCI and PCI-only groups (hazard ratio, 0.789; 95% confidence interval, 0.556–1.120; p = 0.185). After a mean follow-up of 2.5 years, the all-cause mortality rates of patients in the TA + PCI and PCI-only groups were 8.5 and 16.2%, respectively. Additionally, differences between the two groups in terms of the risk of HF, re-PCI, rehospitalization, and stroke were non-significant. However, after dividing into quartiles, as the D-dimer levels increased, the all-cause mortality rate in the PCI group gradually increased (4.3 vs. 6.0 vs. 7.0 vs. 14.7%, p 0.001), while the death rate in the TA+PCI group did not significantly differ (4.6 vs. 5.0 vs. 4.0 vs. 3.75%, p = 0.85). Besides, in the quartile 3 (Q3) and quartile 4 (Q4) groups, the PCI-only group was associated with a higher risk of all-cause mortality than that of the TA+PCI group (Q3: 4.0 vs. 7.0%, p = 0.029; Q4: 3.75 vs. 14.7%, p 0.001). Moreover, the multivariate logistic regression analysis demonstrated that TA is inversely associated with the primary outcome in the Q4 group [odds ratio (OR), 0.395; 95% CI, 0.164–0.949; p = 0.038]. Conclusions: The findings of our real-world study express that routine manual TA during PCI in STEMI did not improve clinical outcomes overall. However, patients with STEMI with a higher concentration of D-dimer might benefit from the use of TA during primary PCI. Large-scale studies are recommended to confirm the efficacy of TA.
机译:目的:评估血栓吸引(TA)策略对患者的结果及其与D-二聚体水平的影响及其在“现实世界”中的初级经皮冠状动脉疗法(PCI)中与D-二聚体水平的影响及其相互作用设置。材料和方法:本研究包括1,295名患有1,295名患有1,295名患者,在2013年1月至2017年1月至2017年6月期间,患者在2013年1月至6月之间进行了无关。患者分为TA + PCI组和仅限PCI群,基线特征和长期分析了两组之间的死亡率。此外,我们研究了TA对根据各自的D-二聚体水平的四分位数进行分组的患者临床结果的影响。主要结果是全导致的死亡率,二次结果是新发病心力衰竭(HF),再生,重新PCI和中风。结果:在原始队列中,TA + PCI和仅PCI组之间的​​所有导致死亡率没有显着差异(危险比,0.789; 95%置信区间,0.556-1.120; p = 0.185)。在平均随访2.5年后,TA + PCI和PCI患者的全因死亡率分别为8.5%和16.2%。另外,两组在HF,Re-PCI,再生和中风风险方面的差异是非显着的。然而,随着D-二聚体水平的增加后,PCI组中的所有原因死亡率逐渐增加(4.3与6.0与7.0 vs.14.7%,P <0.001),而死亡率在TA + PCI组中没有显着差异(4.6与5.0与4.0与3.75%,P = 0.85)。此外,在四分位数3(Q3)和四分位数4(Q4)组中,仅PCI的组与均导致死亡率的风险较高,而不是TA + PCI组(Q3:4.0与7.0%, P = 0.029; Q4:3.75与14.7%,P <0.001)。此外,多变量逻辑回归分析证明TA与Q4组[赔率比(或),0.395; 95%CI,0.164-0.949; p = 0.038]。结论:我们的真实研究结果表明,在STEMI的PCI中的常规手册TA没有完善临床结果。然而,具有较高浓度D-二聚体的STEMI的患者可能会受益于在原发性PCI期间的使用。建议进行大规模研究以确认TA的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号